...
首页> 外文期刊>Clinical and vaccine immunology: CVI >A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test
【24h】

A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test

机译:高百分比的血清样本,测试反应为anti-brucella酶免疫分析法抗体是没有证实的标准管凝集试验

获取原文
获取原文并翻译 | 示例
           

摘要

We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.
机译:我们描述一个回顾性分析布鲁氏菌酶免疫测定(EIA) IgM和免疫球蛋白的结果相比标准的管凝集试验(坐)。测试中,104(9.5%)和24例(2.2%)血清分别由IgM阳性,免疫球蛋白环评。补充测试显示,82.7%和54.2%(86/104)的IgM EIA-reactive样本(13/24)的免疫球蛋白g EIA-reactive样本负面的坐。测试所有EIA screen-reactive样品坐时需要评估病人潜在的布鲁氏菌病。血清学、文化仍然是黄金标准检测布鲁氏菌感染。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号